Martin, Pauline
Wagh, Vilas
Reis, Surya A.
Erdin, Serkan
Beauchamp, Roberta L.
Shaikh, Ghalib
Talkowski, Michael
Thiele, Elizabeth
Sheridan, Steven D.
Haggarty, Stephen J.
Ramesh, Vijaya
Funding for this research was provided by:
U.S. Army Materiel Command (W81XWH-15-1-0414)
National Institute of Neurological Disorders and Stroke (NS109540)
Article History
Received: 19 August 2019
Accepted: 29 December 2019
First Online: 6 January 2020
Ethics approval and consent to participate
: This study of using patient-derived iPSCs was determined as not human subjects research by the Institutional Review Board.
: Not applicable
: SJH is a member of the scientific advisory boards of Frequency Therapeutics, Psy Therapeutics, and Souvien Therapeutics, none of who were involved in this study. SDS is a scientific advisor for Outermost Therapeutics, Inc., which played no part in the present study. The other authors declare no competing interests.